Sumitomo Dainippon

Sumitomo Dainippon

Community score

+1.95 -55
Industry: Biotechnology & Pharmaceuticals
Listing country: Japan
Year added: 2018

Sumitomo Dainippon Pharma Co., Ltd. is a pharmaceutical company formed in 2005 by the merger of Sumitomo Pharmaceuticals Co., Ltd. and Dainippon Pharmaceutical Co., Ltd. Headquartered in Chuo-ku, Osaka, Japan, the company specializes in multiple business segments, including prescription and over-the-counter medications, psychiatric and neurological pharmaceuticals, oncology, and regenerative medicine/cell therapy. Additionally, the company has a significant presence in the international pharmaceutical market, notably through its subsidiaries. Sunovion Pharmaceuticals Inc., a United States-based firm, is recognized for its work in psychiatric and neurological medications. Moreover, Boston Biomedical Inc. is a subsidiary that focuses on oncology. Sumitomo Dainippon Pharma and its associated brands have crucial markets in Japan, the United States, and other parts of the world, and maintain a global presence across North America, Europe, and Asia. (Powered by AI)

Show Company Information
You view a limited profile page without scores and metrics availability. Subscribing users get to see more advanced data, want to see it in action? Click on a company you are interested in: .
My impact scoreBeta
List View
Sumitomo Dainippon

Diseases and illness are leading causes of death globally1. There were 55.4M deaths worldwide in 2019, and diseases were responsible for 74% of them1. The pharmaceutical industry has a crucial role in preventing these deaths, as it involves resear...

User profile picture Ardit N. October 25th, 2021
28 ratings
Sumitomo Dainippon

Diversity and inclusion in the workforce can lead to benefits both for people and companies, with people achieving greater empowerment1. Roughly 650 million people, or 10% of the global population, have some degree of disability2, and global emplo...

Philip B. June 30th, 2021
13 ratings

Most negative / positive SDG

+3.21
-2.74